Navigating Healthcare Disruption

This chapter explores HIMSS's turbulent month after Amazon's disruptive entry into the healthcare market with a pay-per-visit model, initially causing stock declines but later rebounding due to favorable news. It delves into the implications of GLP-1 drug sales on both HIMSS and Walmart, alongside a discussion on how governmental policies may reshape healthcare economics. Additionally, the chapter emphasizes the importance of addressing social determinants of health and the potential risks to crucial healthcare initiatives amidst changing political climates.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app